Wendy Delbart

Rue Meylemeersch 90
Brussels, BRU 1070, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Effect of neoadjuvant chemotherapy on [68Ga]Ga-FAPI-46 PET/CT in peritoneal carcinomatosis: a prospective translational exploratory sub-cohort analysis.

Effect of neoadjuvant chemotherapy on [68Ga]Ga-FAPI-46 PET/CT in peritoneal carcinomatosis: a prospective translational exploratory sub-cohort analysis.

Journal: European journal of nuclear medicine and molecular imaging

Published: April 09, 2026

Noninvasive molecular imaging signatures of histopathological growth patterns in colorectal cancer liver metastases.

Noninvasive molecular imaging signatures of histopathological growth patterns in colorectal cancer liver metastases.

Journal: Clinical & experimental metastasis

Published: November 29, 2025

Toward Personalized Radiopharmaceutical Therapy: Radiobiologic Insights Compared with External-Beam Radiotherapy.

Toward Personalized Radiopharmaceutical Therapy: Radiobiologic Insights Compared with External-Beam Radiotherapy.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: November 17, 2025

Expanding the Horizon of Targeted Radionuclide Therapy: Immunotherapy Combinations and FAP-Targeted Approaches.

Expanding the Horizon of Targeted Radionuclide Therapy: Immunotherapy Combinations and FAP-Targeted Approaches.

Journal: Seminars in nuclear medicine

Published: August 14, 2025

First-in-human experience of radiopharmaceutical therapy with [177Lu]Lu-DOTATATE in patients with advanced multiple myeloma.

First-in-human experience of radiopharmaceutical therapy with [177Lu]Lu-DOTATATE in patients with advanced multiple myeloma.

Journal: EJNMMI reports

Published: June 01, 2025

The SCARLET trial: a prospective phase II study of somatostatin receptor imaging for potential radiotheranostic application in patients with relapsing and refractory multiple myeloma.

The SCARLET trial: a prospective phase II study of somatostatin receptor imaging for potential radiotheranostic application in patients with relapsing and refractory multiple myeloma.

Journal: European journal of nuclear medicine and molecular imaging

Published: March 10, 2025

Evolution of dosimetric parameters through PRRT and potential impact on clinical practice: data from the prospective phase II LUMEN study.

Evolution of dosimetric parameters through PRRT and potential impact on clinical practice: data from the prospective phase II LUMEN study.

Journal: EJNMMI research

Published: August 27, 2024

Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor-2 Expressing Pre-Clinical Models to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE.

Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor-2 Expressing Pre-Clinical Models to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE.

Journal: Cancers

Published: March 03, 2023

Understanding the Radiobiological Mechanisms Induced by 177Lu-DOTATATE in Comparison to External Beam Radiation Therapy.

Understanding the Radiobiological Mechanisms Induced by 177Lu-DOTATATE in Comparison to External Beam Radiation Therapy.

Journal: International journal of molecular sciences

Published: August 22, 2022

Suspicious cold thyroid nodule with intense focal 68Ga-DOTATATE uptake: a case report.

Suspicious cold thyroid nodule with intense focal 68Ga-DOTATATE uptake: a case report.

Journal: European journal of hybrid imaging

Published: November 12, 2021

Investigating intrinsic radiosensitivity biomarkers to peptide receptor radionuclide therapy with [177Lu]Lu-DOTATATE in a panel of cancer cell lines.

Investigating intrinsic radiosensitivity biomarkers to peptide receptor radionuclide therapy with [177Lu]Lu-DOTATATE in a panel of cancer cell lines.

Journal: Nuclear medicine and biology

Published: December 28, 2020

Showing 1-11 of 11

Last Updated: 09/26/2026